Oxford Finance, LLC announced that it has finished helping Chosen Healthcare, which operates expert nursing facilities for a variety of illnesses including Huntington’s disease, to recapitalize and position itself for future growth.
Chosen Healthcare owns 22 expert nursing facilities and one assisted living facility in Indiana, Iowa and Texas. The organization focus is on rehabilitation, as well as assisted and independent living facilities. Chosen Healthcare’s Summerfield Health Care Center is a nationally recognized facility specialized in the care of patients with Huntington’s disease. This center, located in Cloverdale, Indiana, works in close cooperation with the Indiana University Huntington’s Disease Center of Excellence to offer tailored treatment to its patients.
“Oxford appreciates the opportunity to provide capital to Chosen Healthcare to support their thriving and expanding network of long-term care facilities,” Tracy S. Maziek, the managing director at Oxford Finance, said in a press release. “We have done multiple transactions with the management team at Chosen Healthcare, and greatly respect their high operating standards.”
Oxford Finance, which specializes in providing senior debt to life sciences and healthcare services corporations, was the administrative agent and single bookrunner on the unitranche term loan, and the sole lender on the revolver. CIT Bank, N.A., and Opus Bank were co-lenders on the transaction.
The company, headquartered in Alexandria, Virginia, has provided flexible finance solutions to its clients for over 20 years, enabling companies to maximize their equity by leveraging assets. “Oxford has been a reliable source of capital for my firm over several years,” said an executive at Chosen Healthcare. “Having worked with Oxford before, I knew I could depend on them to execute the details of the deal as promised. This was a complex transaction, and it illustrated Oxford’s creativity and ability to work with multiple lenders on large credit facilities.”
Huntington’s disease (HD) is an inherited neurodegenerative disease in which a chromosome defect affects muscle coordination, leading to cognitive decline and to behavioral symptoms.